Geron (GERN) Total Current Liabilities (2010 - 2026)

Geron recorded quarterly Total Current Liabilities of $73.6 million in Q1 2026, down 34.04% quarter-over-quarter from $111.5 million in Q4 2025, and up 16.71% year-over-year from $63.0 million in Q1 2025.

Geron's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $73.6 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 16.71% year-over-year to $73.6 million; the TTM figure through Mar 2026 stood at $73.6 million (up 16.71% YoY), while the FY2025 annual figure was $111.5 million, up 26.32% from the prior year.
  • Total Current Liabilities came in at $73.6 million for Q1 2026 at Geron, down from $111.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $137.9 million in Q3 2024 to a low of $43.9 million in Q1 2023.
  • A 5-year average of $83.5 million and a median of $82.8 million in 2022 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities soared 180.47% in 2024 and slumped 48.82% in 2025, its largest moves.
  • Geron's Total Current Liabilities stood at $76.7 million in 2022, then jumped by 40.91% to $108.1 million in 2023, then decreased by 18.3% to $88.3 million in 2024, then rose by 26.32% to $111.5 million in 2025, then plunged by 34.04% to $73.6 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $73.6 million, $111.5 million, and $87.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 16.35 Mn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 1.70 Mn
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - 66.94 Mn
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 3.88 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 5.11 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 1.35 Bn
10 Geron 856,799.98 856,799.98 - 73.57 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 73.57 Mn
Dec 31, 2025 111.54 Mn
Sep 30, 2025 87.71 Mn
Jun 30, 2025 64.28 Mn
Mar 31, 2025 63.03 Mn
Dec 31, 2024 88.30 Mn
Sep 30, 2024 137.93 Mn
Jun 30, 2024 103.54 Mn
Mar 31, 2024 123.16 Mn
Dec 31, 2023 108.07 Mn
Sep 30, 2023 89.39 Mn
Jun 30, 2023 72.57 Mn
Mar 31, 2023 43.91 Mn
Dec 31, 2022 76.69 Mn
Sep 30, 2022 82.81 Mn
Jun 30, 2022 46.88 Mn
Mar 31, 2022 46.63 Mn
Dec 31, 2021 45.52 Mn
Sep 30, 2021 38.47 Mn
Jun 30, 2021 37.01 Mn
Mar 31, 2021 28.55 Mn
Dec 31, 2020 30.94 Mn
Sep 30, 2020 24.15 Mn
Jun 30, 2020 19.14 Mn
Mar 31, 2020 16.92 Mn
Dec 31, 2019 28.16 Mn
Sep 30, 2019 11.86 Mn
Jun 30, 2019 9.18 Mn
Mar 31, 2019 6.25 Mn
Dec 31, 2018 7.55 Mn
Sep 30, 2018 4.47 Mn
Jun 30, 2018 4.91 Mn
Mar 31, 2018 4.39 Mn
Dec 31, 2017 6.52 Mn
Sep 30, 2017 5.97 Mn
Jun 30, 2017 11.27 Mn
Mar 31, 2017 11.60 Mn
Dec 31, 2016 7.87 Mn
Sep 30, 2016 7.32 Mn
Jun 30, 2016 7.11 Mn
Mar 31, 2016 6.66 Mn
Dec 31, 2015 6.63 Mn
Sep 30, 2015 6.13 Mn
Jun 30, 2015 40.73 Mn
Mar 31, 2015 40.63 Mn
Dec 31, 2014 41.80 Mn
Sep 30, 2014 7.07 Mn
Jun 30, 2014 4.76 Mn
Mar 31, 2014 4.52 Mn
Dec 31, 2013 7.59 Mn
Sep 30, 2013 6.84 Mn
Jun 30, 2013 5.00 Mn
Mar 31, 2013 6.79 Mn
Dec 31, 2012 14.15 Mn
Sep 30, 2012 11.26 Mn
Jun 30, 2012 11.99 Mn
Mar 31, 2012 10.27 Mn
Dec 31, 2011 13.44 Mn
Sep 30, 2011 10.00 Mn
Jun 30, 2011 9.27 Mn
Dec 31, 2010 40.85 Mn